Results 71 to 80 of about 8,686 (179)

Clinical management of neurogenic orthostatic hypotension

open access: yesAnnals of Movement Disorders, 2019
Neurogenic orthostatic hypotension is a common disorder often seen in elderly patients affected with neurodegenerative disorders and peripheral neuropathies.
Malligurki Raghurama Rukmani   +3 more
doaj   +1 more source

Renal tubular acidosis: A ‘basic’ disorder

open access: yes
Equine Veterinary Education, EarlyView.
H. J. Mason, L. G. Arroyo
wiley   +1 more source

The Promise and Pitfalls of Biomarkers for Differential Diagnosis in Parkinson’s Disease and Atypical Parkinsonism

open access: yesInternational Journal of Clinical Practice, Volume 2026, Issue 1, 2026.
Parkinson’s disease (PD) and atypical parkinsonian syndromes (APSs) present diagnostic challenges due to overlapping clinical features. Misdiagnosis rates exceed 25% for PD and 50% for APS, highlighting the need for improved diagnostic methods. To review current diagnostic approaches and explore the potential of plasma biomarkers in differentiating PD ...
Fatuma Mohamed Aden   +8 more
wiley   +1 more source

Safety and Efficacy of Fludrocortisone in the Treatment of Cerebral Salt Wasting in Patients With Tuberculous Meningitis: A Randomized Clinical Trial

open access: yesJAMA Neurology, 2018
Importance Tuberculous meningitis is associated with high frequency of cerebral salt wasting. There is a paucity of objective information regarding the best method of treatment of this condition.
U. Misra, J. Kalita, Mritunjai Kumar
semanticscholar   +1 more source

Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 12, Page 2671-2690, December 2025.
Main categories of harmful drugs in heart failure. CCB, calcium channel blocker; DPP4i, dipeptidyl peptidase‐4 inhibitor; HER2‐TT, human epidermal growth factor receptor 2‐targeted therapy; NSAID, non‐steroidal anti‐inflammatory drug; TKI, tyrosine kinase inhibitor; TZD, thiazolidinedione; VEGF Inh, vascular endothelial growth factor inhibitor.
Amr Abdin   +16 more
wiley   +1 more source

The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone

open access: yesJournal of the Renin-Angiotensin-Aldosterone System, 2019
Introduction: AZD9977 is a novel mineralocorticoid receptor (MR) modulator, which in preclinical studies demonstrated organ protection without affecting aldosterone-regulated urinary electrolyte excretion.
K. Bamberg   +4 more
semanticscholar   +1 more source

Corticotherapy for traumatic brain-injured Patients - The Corti-TC trial: study protocol for a randomized controlled trial

open access: yesTrials, 2011
Background Traumatic brain injury (TBI) is a main cause of severe prolonged disability of young patients. Hospital acquired pneumonia (HAP) add to the morbidity and mortality of traumatic brain-injured patients. In one study, hydrocortisone for treatment
Asehnoune Karim   +3 more
doaj   +1 more source

Aldosterone synthase deficiency associated with a CYP11B2 variant of uncertain significance: Case report and literature review

open access: yesJournal of Clinical and Translational Endocrinology Case Reports
Congenital aldosterone synthase deficiency (ASD) is a rare autosomal recessive condition that causes isolated primary hypoaldosteronism. It has been associated with different pathogenic mutations of the CYP11B2 gene.
Bayan AlNassir, Hessah AlOtaibi
doaj   +1 more source

A Bulking Agent May Lead to Adrenal Insufficiency Crisis: A Case Report [PDF]

open access: yesActa Medica Iranica, 2011
Adrenal insufficiency is a life-threatening disorder which must be treated with glucocorticoid replacement and needs permanent dose adjustment during patient's different somatic situations.
Seyed Hossein Samadanifard   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy